For: | Akpolat N, Yahsi S, Godekmerdan A, Demirbag K, Yalniz M. Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B. World J Gastroenterol 2005; 11(21): 3260-3263 [PMID: 15929178 DOI: 10.3748/wjg.v11.i21.3260] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i21/3260.htm |
Number | Citing Articles |
1 |
Abdel-Rahman N Zekri, Hanaa M Alam El-Din, Abeer A Bahnassy, Naglaa A Zayed, Waleed S Mohamed, Suzan H El-Masry, Sayed K Gouda, Gamal Esmat. Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4. Comparative Hepatology 2010; 9(1) doi: 10.1186/1476-5926-9-1
|
2 |
Ki Tae Suk, Dae Yong Kim, Kyoung Min Sohn, Dong Joon Kim. . Advances in Clinical Chemistry 2013; 62: 33 doi: 10.1016/B978-0-12-800096-0.00002-0
|
3 |
Roli Saxena, Yogesh Kumar Chawla, Indu Verma, Jyotdeep Kaur. Effect of IL-12B, IL-2, TGF-β1, and IL-4 Polymorphism and Expression on Hepatitis B Progression. Journal of Interferon & Cytokine Research 2014; 34(2): 117 doi: 10.1089/jir.2013.0043
|
4 |
Jen-Sing Jeng, Jung-Fa Tsai, Lee-Yea Chuang, Mei-Shang Ho, Zu-Yau Lin, Min-Yuh Hsieh, Shin-Chern Chen, Wan-Lung Chuang, Liang-Yen Wang, Ming-Lung Yu, Chia-Yen Dai, Jan-Gowth Chang. Tumor Necrosis Factor-α 308.2 Polymorphism Is Associated with Advanced Hepatic Fibrosis and Higher Risk for Hepatocellular Carcinoma. Neoplasia 2007; 9(11): 987 doi: 10.1593/neo.07781
|
5 |
Yongjung Park, Jun Yong Park, Kwang-Hyub Han, Hyon-Suk Kim. Serum cytokine levels in chronic hepatitis B patients receiving peginterferon alpha-2a therapy. Hepatobiliary & Pancreatic Diseases International 2012; 11(5): 499 doi: 10.1016/S1499-3872(12)60214-8
|
6 |
Xiangmei Chen, Ling Zhang, Yibin Chang, Tao Shen, Ling Wang, Hui Zhuang, Fengmin Lu. Association of TNF-α Genetic Polymorphisms with Hepatocellular Carcinoma Susceptibility: A Case-Control Study in a Han Chinese Population. The International Journal of Biological Markers 2011; 26(3): 181 doi: 10.5301/JBM.2011.8580
|
7 |
Yoav Lurie, Muriel Webb, Ruth Cytter-Kuint, Shimon Shteingart, Gerardo Z Lederkremer. Non-invasive diagnosis of liver fibrosis and cirrhosis. World Journal of Gastroenterology 2015; 21(41): 11567-11583 doi: 10.3748/wjg.v21.i41.11567
|
8 |
Younhee Park, Yongjung Park, Kwang‐Hyub Han, Hyon‐Suk Kim. Serum cytokine levels in patients with chronic hepatitis B according to lamivudine therapy. Journal of Clinical Laboratory Analysis 2011; 25(6): 414 doi: 10.1002/jcla.20495
|
9 |
Alessandra Marchetti, Francesca Bisceglia, Angela Cozzolino, Marco Tripodi. New Tools for Molecular Therapy of Hepatocellular Carcinoma. Diseases 2015; 3(4): 325 doi: 10.3390/diseases3040325
|
10 |
Mengmeng Li, Yang Zhuo, Ying Xu, Hao Chen, Zheng Cheng, Li Zhou. Genetic Association of Interleukin-6 Polymorphism (rs1800796) with Chronic Hepatitis B Virus Infection in Chinese Han Population. Viral Immunology 2021; 34(4): 267 doi: 10.1089/vim.2020.0211
|
11 |
Harmeet Malhi, Gregory J. Gores. Schiff's Diseases of the Liver. 2017; : 200 doi: 10.1002/9781119251316.ch7
|
12 |
Yu-Chi Chou, Mong-Liang Chen, Cheng-Po Hu, Ya-Ling Chen, Chin-Liew Chong, Yue-Lin Tsai, Tzu-Ling Liu, King-Song Jeng, Chungming Chang. Transforming growth factor-β1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA. Hepatology 2007; 46(3): 672 doi: 10.1002/hep.21726
|
13 |
Kang Wook Jung, Eunyoung Ha, Gyeong Im Yu, Sung Jin Kim, Woo Jin Chung, Byoung Kuk Jang, Jung Jeung Lee, Dong Hoon Shin, Jae Seok Hwang. TNFα promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population. Clinica Chimica Acta 2009; 407(1-2): 16 doi: 10.1016/j.cca.2009.06.013
|
14 |
ML Giles, M‐A Davey, EM Wallace. Chronic hepatitis B infection and the risk of gestational diabetes: a cross‐sectional study. BJOG: An International Journal of Obstetrics & Gynaecology 2020; 127(9): 1147 doi: 10.1111/1471-0528.16217
|
15 |
Bao-Hong Wang, Jing Guo, Lan-Juan Li, Tao Chen, Chun-Xia Guo, Yong-Wen He. Acute Exacerbation of Chronic Hepatitis B. 2019; : 315 doi: 10.1007/978-94-024-1606-0_6
|
16 |
E. Loggi, A. Gramenzi, M. Margotti, C. Cursaro, S. Galli, G. Vitale, E. Grandini, A. Scuteri, R. Vukotic, P. Andreone, M. Bernardi. In vitro effect of thymosin‐alpha1 and interferon‐alpha on Th1 and Th2 cytokine synthesis in patients with eAg‐negative chronic hepatitis B. Journal of Viral Hepatitis 2008; 15(6): 442 doi: 10.1111/j.1365-2893.2007.00960.x
|
17 |
Tianhui Liu, Xiaoming Wang, Morten A. Karsdal, Diana J. Leeming, Federica Genovese. Molecular Serum Markers of Liver Fibrosis. Biomarker Insights 2012; 7: BMI.S10009 doi: 10.4137/BMI.S10009
|
18 |
T. L. Rothstein, B. Guo. Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity‐associated cytokine, osteopontin. Journal of Internal Medicine 2009; 265(6): 632 doi: 10.1111/j.1365-2796.2009.02103.x
|
19 |
Guoyu Zhang, Zhu Li, Qunying Han, Na Li, Qianqian Zhu, Fang Li, Yi Lv, Jinghong Chen, Sai Lou, Zhengwen Liu. Altered TNF-α and IFN-γ levels associated with PD1 but not TNFA polymorphisms in patients with chronic HBV infection. Infection, Genetics and Evolution 2011; 11(7): 1624 doi: 10.1016/j.meegid.2011.06.004
|
20 |
Ji Yeon Kim, Eun Hyun Song, Hyun Jung Lee, Yeo Kyoung Oh, Kyung-Hee Choi, Dae-Yeul Yu, Sang Ick Park, Je-Kyung Seong, Won-Ho Kim. HBx-Induced Hepatic Steatosis and Apoptosis Are Regulated by TNFR1- and NF-κB-Dependent Pathways. Journal of Molecular Biology 2010; 397(4): 917 doi: 10.1016/j.jmb.2010.02.016
|
21 |
Ikram Sghaier, Sabrina Zidi, Leila Mouelhi, Radhouane Dabbech, Ezzedine Ghazouani, Etienne Brochot, Mouna Stayoussef, Besma Yacoubi-Loueslati. The relationship between TNF alpha gene polymorphisms (−238/−308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population. Gene 2015; 568(2): 140 doi: 10.1016/j.gene.2015.05.029
|
22 |
Hossein Khorramdelazad, Gholamhossein Hassanshahi, Behzad Ahmadabadi, Mohammad Kazemi Arababadi. High serum levels of TGF-β in Iranians with chronic HBV infection. Hepatitis Monthly 2012; 12(11) doi: 10.5812/hepatmon.7581
|
23 |
Ashok Kumar, Salam Gyaneshwori Devi, Premashis Kar, Sarita Agarwal, Syed Akhtar Husain, Ram Kumar Gupta, Shashi Sharma. Association of cytokines in hepatitis E with pregnancy outcome. Cytokine 2014; 65(1): 95 doi: 10.1016/j.cyto.2013.09.022
|
24 |
Antonia Mourtzikou, Maria Alepaki, Marilena Stamouli, Abraham Pouliakis, Anastasios Skliris, Petros Karakitsos. Evaluation of serum levels of IL-6, TNF-α, IL-10, IL-2 and IL-4 in patients with chronic hepatitis. Inmunología 2014; 33(2): 41 doi: 10.1016/j.inmuno.2014.01.001
|
25 |
Yong-Qiong Deng, Hong Zhao, An-Lin Ma, Ji-Yuan Zhou, Shi-Bin Xie, Xu-Qing Zhang, Da-Zhi Zhang, Qing Xie, Guo Zhang, Jia Shang, Jun Cheng, Wei-Feng Zhao, Zhi-Qiang Zou, Ming-Xiang Zhang, Gui-Qiang Wang. Selected Cytokines Serve as Potential Biomarkers for Predicting Liver Inflammation and Fibrosis in Chronic Hepatitis B Patients With Normal to Mildly Elevated Aminotransferases. Medicine 2015; 94(45): e2003 doi: 10.1097/MD.0000000000002003
|
26 |
Harmeet Malhi, Gregory J. Gores. Schiff's Diseases of the Liver. 2011; : 216 doi: 10.1002/9781119950509.ch8
|
27 |
F. Zhang, Y.‐C. Fan, N.‐N Mu, J. Zhao, F.‐K. Sun, Z.‐H. Zhao, S. Gao, K. Wang. Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection. Journal of Viral Hepatitis 2014; 21(4): 241 doi: 10.1111/jvh.12136
|
28 |
XUENI LIU, ZHENGHAO TANG, YI ZHANG, JIANJUN HU, DAN LI, GUOQING ZANG, YONGSHENG YU. Lentivirally overexpressed T-bet regulates T-helper cell lineage commitment in chronic hepatitis B patients. Molecular Medicine Reports 2012; 6(2): 361 doi: 10.3892/mmr.2012.905
|
29 |
Lu Wang, Junzhong Wang, Yana Liu, Baoju Wang, Shangqing Yang, Qing Yu, Michael Roggendorf, Mengji Lu, Jia Liu, Dongliang Yang. Molecular cloning, characterization and expression analysis of TGF-β and receptor genes in the woodchuck model. Gene 2016; 595(1): 1 doi: 10.1016/j.gene.2016.09.018
|
30 |
Fahad N. Almajhdi, Ahmed Y. Al-Qudari, Zahid Hussain. Differential expression of transforming growth factor-ßl and HBx enhances hepatitis B virus replication and augments host immune cytokines and chemokines. Annals of Hepatology 2013; 12(3): 408 doi: 10.1016/S1665-2681(19)31003-8
|
31 |
Seyed Hedayat Hosseini Khorami, Foroogh Nejatollahi, Mohammad Ali Davarpanah. Serum Levels of Interleukin-4, Interleukin-10 and Interferon-γ in Patients with Chronic Hepatitis B Infection. Hepatitis Monthly 2018; 18(4) doi: 10.5812/hepatmon.60377
|
32 |
Ming-Hsiang Hong, Yu-Chi Chou, Yi-Chieh Wu, Kuen-Nan Tsai, Cheng-po Hu, King-Song Jeng, Mong-Liang Chen, Chungming Chang, Wang-Shick Ryu. Transforming Growth Factor-β1 Suppresses Hepatitis B Virus Replication by the Reduction of Hepatocyte Nuclear Factor-4α Expression. PLoS ONE 2012; 7(1): e30360 doi: 10.1371/journal.pone.0030360
|
33 |
S. K. Das, D. M. Vasudevan. Genesis of hepatic fibrosis and its biochemical markers. Scandinavian Journal of Clinical and Laboratory Investigation 2008; 68(4): 260 doi: 10.1080/00365510701668516
|
34 |
Tung-Hung Su, Jia-Horng Kao, Chun-Jen Liu. Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis. International Journal of Molecular Sciences 2014; 15(6): 10578 doi: 10.3390/ijms150610578
|
35 |
Jian Ge, Kai Wang, Qing-Hua Meng, Zhao-Xia Qi, Fan-Li Meng, Yu-Chen Fan. Implication of Th17 and Th1 Cells in Patients with Chronic Active Hepatitis B. Journal of Clinical Immunology 2010; 30(1): 60 doi: 10.1007/s10875-009-9328-2
|
36 |
Gianluigi Giannelli, Antonio Mazzocca, Emilia Fransvea, Michael Lahn, Salvatore Antonaci. Inhibiting TGF-β signaling in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2011; 1815(2): 214 doi: 10.1016/j.bbcan.2010.11.004
|
37 |
Yan Chen, Xia Xie, Lin Gu, Xiao‐Hui Huang, Xiao‐Mou Peng. Furin mRNA expression in peripheral blood correlates with chronic hepatitis B virus infection. Hepatology Research 2013; 43(2): 208 doi: 10.1111/j.1872-034X.2012.01051.x
|
38 |
Naeem Khan, Yongmei Hu, Clifford A. Lowell, Thomas L. Rothstein. Signal Integration by Translocation and Phosphorylation of PKCδ in the B Cell Alternate Pathway. The Journal of Immunology 2021; 207(9): 2288 doi: 10.4049/jimmunol.2100295
|
39 |
Hong-Lei Weng, Yan Liu, Jia-Lin Chen, Tong Huang, Li-Jun Xu, Patricio Godoy, Jun-Hua Hu, Cheng Zhou, Felix Stickel, Alexander Marx, Rainer M. Bohle, Vincent Zimmer, Frank Lammert, Sebastian Mueller, Michelle Gigou, Didier Samuel, Peter R. Mertens, Manfred V. Singer, Helmut K. Seitz, Steven Dooley. The etiology of liver damage imparts cytokines transforming growth factor β1 or interleukin-13 as driving forces in fibrogenesis #. Hepatology 2009; 50(1): 230 doi: 10.1002/hep.22934
|
40 |
Nora Alma Fierro, Sonia Roman, Mauricio Realpe, Zamira Hernandez-Nazara, Eloy Alfonso Zepeda-Carrillo, Arturo Panduro. Multiple cytokine expression profiles reveal immune-based differences in occult hepatitis B genotype H-infected Mexican Nahua patients. Memórias do Instituto Oswaldo Cruz 2011; 106(8): 1007 doi: 10.1590/S0074-02762011000800018
|
41 |
Caroline Lefeuvre, Marine Roux, Simon Blanchard, Hélène Le Guillou-Guillemette, Jérôme Boursier, Françoise Lunel-Fabiani, Pascale Jeannin, Adeline Pivert, Alexandra Ducancelle. Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutants. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-14285-9
|
42 |
Shiyao Huang, Jing Wang, Yiquan Xiong, Chunrong Liu, Yana Qi, Kang Zou, Jing Tan, Xin Sun. Impact of maternal hepatitis B carrier status on congenital abnormalities: a systematic review and meta-analysis. BMJ Open 2023; 13(3): e066017 doi: 10.1136/bmjopen-2022-066017
|
43 |
|